- The US Food and Drug Administration has expanded the approved indication for Enstilar (calcipotriene and betamethasone dipropionate
) Foam, 0.005%/0.064%, for the topical treatment of plaque psoriasis to include patients age 12 and older, US-based medical dermatology company Leo Pharma Inc., a wholly owned subsidiary of Denmark-based Leo Pharma A/S, said.
For example, betamethasone dipropionate
0.05% in an ointment is considered a class I super potent steroid, whereas the same ingredient at the same concentration in a spray is a class III steroid.
Keywords: Betamethasone dipropionate
, Calcipotriene, Vitiligo.
KeyWords: Betametasone dipropionate
, Calcipotriol, Chronic plaque psoriasis
One study showed that 7 of 10 (70%) of children taking maintenance doses of beclomethasone dipropionate
had growth impairment after 6 months of therapy.
Mathias Tiedemann Svendsen, M.D., from Odense University Hospital in Denmark, and colleagues randomized 122 patients who were receiving once-daily medication (calcipotriol/betamethasone dipropionate
[Cal/BD] cutaneous foam) to either no app (66 patients) or an app intervention (68 patients).
M2 EQUITYBITES-February 20, 2018-Teva Pharmaceutical in US launch of QVAR RediHaler (beclomethasone dipropionate
HFA) Inhalation Aerosol
Topical calcipotriol/betamethasone dipropionate
is a yellow-to-white substance including 50 [micro]g/g calcipotriol and 500 [micro]g/g betamethasone dipropionate
In a study by Kumar et al., 5% crude coal tar ointment was shown to induce 75% reduction in erythema severity index (ESI) in 59% of patients at 12 weeks. Betamethasone dipropionate
is a relatively new topical agent and there are numerous studies to document its efficacy in psoriasis.
market introduction of its calcipotriene and betamethasone dipropionate
ointment, the first generic version of Leo Pharma's Taclonex ointment.
Horses of group A, were treated with pentamidine methunsulphate at a dose rate of 3 mg/kg body weight intravenously, horses of group B were treated with imidocarb dipropionate
at a dose rate of 2.4 mg/kg body weight intramuscularly, while horses of group C were treated with diminazene diaceturate at a dose rate of 3.5mg/kg bodyweight intramuscularly.